APA

Hesselink A. T., Meijer C. J. L. M., Poljak M., Berkhof J., van Kemenade F. J., van der Salm M. L., Bogaarts M., Snijders P. J. F. & Heideman D. A. M. (20131216). Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. : Journal of clinical microbiology.

Chicago

Hesselink A T, Meijer C J L M, Poljak M, Berkhof J, van Kemenade F J, van der Salm M L, Bogaarts M, Snijders P J F and Heideman D A M. 20131216. Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. : Journal of clinical microbiology.

Harvard

Hesselink A. T., Meijer C. J. L. M., Poljak M., Berkhof J., van Kemenade F. J., van der Salm M. L., Bogaarts M., Snijders P. J. F. and Heideman D. A. M. (20131216). Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. : Journal of clinical microbiology.

MLA

Hesselink A T, Meijer C J L M, Poljak M, Berkhof J, van Kemenade F J, van der Salm M L, Bogaarts M, Snijders P J F and Heideman D A M. Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. : Journal of clinical microbiology. 20131216.